Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.
On Wednesday, Perspecta's Director, Philip O. Nolan, made a $100,331 purchase of PRSP, buying 4,366 shares at a cost of $22.98 each. Nolan was up about 4.9% on the purchase at the high point of today's trading session, with PRSP trading as high as $24.10 at last check today. Perspecta is trading up about 1.2% on the day Monday. Before this latest buy, Nolan purchased PRSP at 3 other times during the past twelve months, for a total investment of $302,288 at an average of $22.07 per share.
And at Acer Therapeutics, there was insider buying on Wednesday, by Director Steve Aselage who purchased 5,000 shares at a cost of $3.72 each, for a trade totaling $18,581. Acer Therapeutics is trading up about 0.9% on the day Monday. Bargain hunters are able to pick up ACER at a price even lower than Aselage did, with shares trading as low as $3.28 in trading on Monday — that's 11.7% below Aselage's purchase price.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.